Works matching IS 03407004 AND DT 2016 AND VI 65 AND IP 3


Results: 10
    1

    Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.

    Published in:
    Cancer Immunology, Immunotherapy, 2016, v. 65, n. 3, p. 327, doi. 10.1007/s00262-016-1796-7
    By:
    • Bol, Kalijn;
    • Aarntzen, Erik;
    • Pots, Jeanette;
    • Olde Nordkamp, Michel;
    • Rakt, Mandy;
    • Scharenborg, Nicole;
    • Boer, Annemiek;
    • Oorschot, Tom;
    • Croockewit, Sandra;
    • Blokx, Willeke;
    • Oyen, Wim;
    • Boerman, Otto;
    • Mus, Roel;
    • Rossum, Michelle;
    • Graaf, Chantal;
    • Punt, Cornelis;
    • Adema, Gosse;
    • Figdor, Carl;
    • Vries, I.;
    • Schreibelt, Gerty
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9

    The induction of human myeloid derived suppressor cells through hepatic stellate cells is dose-dependently inhibited by the tyrosine kinase inhibitors nilotinib, dasatinib and sorafenib, but not sunitinib.

    Published in:
    Cancer Immunology, Immunotherapy, 2016, v. 65, n. 3, p. 273, doi. 10.1007/s00262-015-1790-5
    By:
    • Heine, Annkristin;
    • Schilling, Judith;
    • Grünwald, Barbara;
    • Krüger, Achim;
    • Gevensleben, Heidrun;
    • Held, Stefanie;
    • Garbi, Natalio;
    • Kurts, Christian;
    • Brossart, Peter;
    • Knolle, Percy;
    • Diehl, Linda;
    • Höchst, Bastian
    Publication type:
    Article
    10